|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | CMV IgG ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Endothelial Lipase (EL) C-Terminal ELISA | Tenascin-C High Molecular Weight Variants ELISA Assay | Varicella-Zoster Virus (VZV) IgG ELISA |
| Citations | | | | | |
| Catalog Number | IB19205 | TM09036 | 27263 | 27751 | IB79889 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of IgG antibody to Cytomegalovirus (CMV) in human serum or plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Endothelial Lipase (EL) C-Terminal in human serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Tenascin-C containing high molecular weight variants (Human Tenascin-C HMWV) in serum, plasma (heparin), or cell culture media. For research use only, not for use in diagnostic procedures. | The Varicella-Zoster Virus (VZV) IgG ELISA is intended for the determination of IgG class antibodies against Varicella-Zoster Virus (VZV) in human serum or plasma (citrate, heparin). For research use only - not for use in diagnostic procedures. |
| Detection Target | Deamidated Gliadin IgG | sAPP Total | Noradrenaline | CA 242 | Strongyloides IgG / IgM |
| Sample Type | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Multiple | Serum | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | Inquire | Anti-Ustekinumab (Stelara®) | 0 / 0.13 to 8 ng/mL | 0.38 to 24 ng/mL | A cut-off control is used for the interpretation of results. |
| Sensitivity | 0.706 | 0.06 ng/mL | 0.1 ng/mL x Correction Factor (please see protocol) | Inquire | 0.879 |
| Assay Time | 50 mins (incubation) | 2 hour, 30 min. total incubation time. | Overnight + 30 min. (incubation) | 2 hrs (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |